Transplant & Gen Surgery Spec Allentown, PA - 18103

Transplant & Gen Surgery Spec is categorized under Doctors in Allentown, PA .

Transplant & Gen Surgery Spec was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Elyse Keernan, Office Manager at the company’s single location by writing to 1250 South Cedar Crest Boulevard # 210, Allentown, Pennsylvania PA 18103 or by phoning (610) 402-8506. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Transplant & Gen Surgery Spec
Contact Person: Elyse Keernan, Office Manager
Address: 1250 South Cedar Crest Boulevard # 210, Allentown, Pennsylvania 18103
Phone Number: (610) 402-8506
Website Address: lvhn.org
Annual Revenue (USD): $2.500.000 to $4.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Transplant & Gen Surgery Spec was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Elyse Keernan, Office Manager for inquiries that concern Transplant & Gen Surgery Spec by calling the company number (610) 402-8506, as your correspondence is most welcome. Additionally, the physical location of the single location of Transplant & Gen Surgery Spec can be found at the coordinates 40.566,-75.5185 as well as the street address 1250 South Cedar Crest Boulevard # 210 in Allentown, Pennsylvania 18103.

For its online presence, you may visit Transplant & Gen Surgery Spec’s website at lvhn.org and engage with its social media outlets through on Twitter and on Facebook.